Experience with long-term use of certolizumab pegol (Cimzia)
<p>Objective: to establish whether long-term combination therapy with a tumor necrosis factor (TNF) α inhibitor and a disease-modifying antirheumatic drug (DMARD) (methotrexate – MTX) may lead to sustained rheumatoid arthritis (RA) remission and its maintenance even after discontinuation of genetica...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
IMA-PRESS LLC
2013-10-01
|
| Sarja: | Современная ревматология |
| Aiheet: | |
| Linkit: | http://mrj.ima-press.net/index.php/mrj/article/view/496 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|